Applicants must read and follow all application instructions in the Application Guide as well as any program-specific instructions noted in Section IV.
Studies identifying mechanisms of resilience and recovery in schizophrenia and related psychotic disorders in mid- to late-life.
New methods should be incorporated into an underlying scientific question about schizophrenia and related psychotic disorders in mid- to late-life.
The NIMH has published updated policies and guidance for investigators regarding human research protection and clinical research data and safety monitoring (NOT-MH-19-027).
For assistance with application submission, contact the Application Submission Contacts in Section VII.

PAR-25-039: Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)